Edition:
United Kingdom

Allogene Therapeutics Inc (ALLO.OQ)

ALLO.OQ on NASDAQ Stock Exchange Global Select Market

31.24USD
15 Feb 2019
Change (% chg)

$0.10 (+0.32%)
Prev Close
$31.14
Open
$31.13
Day's High
$31.69
Day's Low
$30.22
Volume
64,729
Avg. Vol
--
52-wk High
$35.55
52-wk Low
$21.67

Chart for

About

Allogene Therapeutics, Inc. is a clinical stage immuno-oncology company. The Company is focused on developing and commercializing of allogeneic T cell therapies for the treatment of cancer. It is involved in developing a pipeline of multiple allogeneic chimeric antigen receptor (CAR) T cell product candidates utilizing protein... (more)

Overall

No Ratios Available.

Financials

  ALLO.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -- -- --
ROI: -- 8.92 14.45
ROE: -- 10.08 15.96

Earnings vs. Estimates